INTRODUCTION Approximately 1.6 million people in the United States have type 1 diabetes (T1D).1 The incidence of T1D is increasing in…
INTRODUCTION Since the discovery of insulin 100 years ago, there have been continual advances in medications and technologies for the management…
Objective The prevalence of depression among adolescents with type 1 diabetes is estimated to be 2–3 times higher than in…
Importance A low-burden electronic health record (EHR) workflow has been devised to systematize the collection and validation of 6 key diabetes…
Background: The benefits of Continuous Glucose Monitoring (CGM) on glycemic management have been demonstrated in numerous studies; however, widespread uptake…
Context COVID-19 morbidity and mortality are increased in type 1 diabetes (T1D), but few data focus on age-based outcomes. Objective…
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative…
Medical advances, including the development of new medications and advanced technologies, have the potential to improve outcomes for youths and…
Despite immense strides in therapeutic advances, clinical outcomes continue to be less than ideal for people with type 1 diabetes.…
Insulin pump therapy in pediatric type 1 diabetes has been associated with better glycemic control than multiple daily injections. However,…